T 1153/17 (Botulinum toxin assays/ALLERGAN) of 28.07.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T115317.20200728
- Date of decision
- 28 July 2020
- Case number
- T 1153/17
- Petition for review of
- -
- Application number
- 09719709.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Immuno-based botulinum toxin serotype A activity assays
- Applicant name
- Allergan, Inc.
- Opponent name
- Ipsen Pharma S.A.S.
Merz Pharma GmbH & Co. KGaA - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Amendments - added subject-matter (no)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside. The patent is maintained as granted.
2. The appeals of appellants II and III are dismissed.